ArticleFrontiers in medicine2026
Enhanced preoperative prediction for microvascular invasion in hepatocellular carcinoma through an optimized MR Radiomics combination strategy and machine learning predictor.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is a crucial step toward personalized treatment, improved treatment outcomes, and enhanced patient survival. However, the disadvantage of existing prediction models of MVI in HCC based on enhanced magnetic resonance imaging (MRI) is that they require combining non-imaging information from enhanced MRI, or determining the perioperative region is highly subjective. These disadvantages are not conducive to the clinical application of predictive models, which hinders clinical decision-making and management for these vulnerable populations. Methods: To address the problem of combining non-imaging information from enhanced MRI with the highly subjective determination of the perioperative region, we propose an enhanced preoperative prediction model for MVI in HCC using an optimized MR Radiomics combination strategy and a machine learning predictor. First, the HCC was manually segmented from 125 × 512 × 512 × Results: The proposed MVI preoperative prediction model (RF + LASSO + SPECTRAL-10) achieves a mean accuracy of 0.7520 ± 0.0867, a mean precision of 0.7354 ± 0.1863, a mean recall of 0.6955 ± 0.2203, a mean Discussion: The proposed best preoperative prediction model can effectively predict MVI in HCC, potentially serving as a strong decision-making tool for these vulnerable populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.